If you have been reading about heptapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-11. Numbers and descriptions here follow the published literature rather than marketing material.
The peptide is prone to several degradation pathways. Oxidation of the methionine residue produces a sulfoxide that elutes close to the parent peak in many chromatographic systems. Hydrolysis of peptide bonds and deamidation of susceptible residues in related sequences also reduce purity over time. Lyophilised material kept dry at minus twenty degrees Celsius and shielded from light is the most stable form commonly described in laboratory practice.
Material sold for laboratory use varies widely in stated purity and documentation. A certificate of analysis should list the analytical method, the column and detector used, and the observed purity value. Independent verification by an outside laboratory is the practical way to confirm identity when documentation is absent or internally inconsistent. Regulatory status differs by country, and a product legal in one jurisdiction may be unapproved or controlled in another.
Identity and purity of semax are established with reversed-phase high-performance liquid chromatography coupled to ultraviolet detection, usually at 214 nanometres. Mass spectrometry, most often electrospray ionisation in positive mode, confirms the molecular mass and reveals truncated sequences. Amino acid analysis and peptide mapping after enzymatic digestion provide additional structural confirmation. Laboratories typically report purity as the percentage area of the main peak, a figure that does not capture isomeric or oxidised variants unless the method resolves them.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised solid |
| Solubility class | Freely soluble in water | Also dissolves in aqueous buffers |
| Typical storage temperature | -20 °C | Dry, desiccated, protected from light |
| Typical analytical method | RP-HPLC with UV detection | Often paired with LC-MS |
| Water content | Reported as Karl Fischer value | Freeze-dried material is hygroscopic |
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
纯度评估以反相高效液相色谱为主，通过主峰面积百分比给出粗略结果，再配合电喷雾质谱核对分子量。氨基酸分析可验证组成比例，手性色谱或毛细管电泳用于检查残基构型。常见杂质包括缺失序列的短肽、氧化产物与二聚体。由于多数市售品不附带完整检验报告，独立第三方检测常被用来核实标称值。
从分子层面看，Semax 是线性七肽，没有二硫键、糖基或脂链修饰，N 端为游离氨基，C 端为游离羧基。分子含组氨酸与谷氨酸侧链，因此在水和甲醇等极性溶剂中溶解良好，在非极性溶剂中溶解有限。计算分子量约为 814 Da，与其质子化离子的质荷比吻合，可用于质谱确认。
== Function == The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDKs (cyclin-dependent kinase). Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis.
== Design considerations == Fabricating artificial skin has the difficulty of mimicking living tissue with similar biological and mechanical performance. As outlined by Integra founders Yannas and Burke, there are three key factors to consider in the creation of artificial skin: material, bio/physiochemical properties, and mechanical properties.
=== Neonatal abstinence syndrome === Several studies have documented neonatal abstinence syndrome, a syndrome of neurological, gastrointestinal, autonomic, endocrine, and/or respiratory symptoms among a large minority of infants with intrauterine exposure. These syndromes are short-lived, but insufficient long-term data are available to determine whether there are long-term effects.
Sources: en.wikipedia.org
== Research == According to an umbrella review of 41 systematic reviews and meta-analyses of 303 observational studies, there is suggestive evidence for beneficial associations in gastric cancer, lung cancer, endometrial cancer, and all-cause mortality.
This should in no way suggest to clinicians or researchers that inhaled particles are not a greater threat than swallowed particles, it merely signifies that a combination of both methods may occur with some particles, no matter the size of or lipo/hydrophilicity of the different particle surfaces.
In the push for large research accelerators, HVEC outgrew the space available in its Cambridge auto garage. The company opened a production plant on Route 128 in Burlington, Massachusetts in 1957. At the recommendation of board member Doriot, the company also opened a Dutch subsidiary, High Voltage Engineering Europa, to supply accelerators in the European common market. Western reaction to the 1957 launch of Sputnik transformed the commercial opportunities for nuclear instrumentation. Laboratories had typically built their own accelerators from scratch. After Sputnik, the Atomic Energy Commission and National Science Foundation generously funded university and national laboratory purchases of research particle accelerators. HVEC's reliable, manufactured machines became the preferred instrument. Over fifteen years, HVEC sold 55 tandem accelerators to research laboratories in seven countries, selling each for $1–3 million. By the mid-1970s, nearly 70% of papers in experimental nuclear physics relied on data from HVEC accelerators. HVEC entered the 1960s as the nation's leading manufacturer of particle accelerators and was the single best investment ARD had made. Annual sales climbed from $1 million in 1954 to $17 million in 1962. At the time of its public listing on the New York Stock Exchange in 1963, HVEC was more than 40% of ARD's portfolio assets, having grown ARD's original $0.2M investment to $13.2 million.
== Awards and honours == 2004 CWA Ian Fleming Steel Dagger Award shortlist for Dead I Well May Be 2007 Audie Award for Best Thriller/Suspense for The Dead Yard. 2008 Young Hoosier Award and Beehive Award shortlist for The Lighthouse Land 2009 World Book Day Award longlist for The Bloomsday Dead 2010 Spinetingler Award for Best Novel for Fifty Grand 2011 Theakston Old Peculier Crime Novel of the Year Award longlist for Fifty Grand 2013 Spinetingler Award for Best Crime Novel for The Cold Cold Ground 2013 Prix Du Meilleur Polar shortlist for The Cold Cold Ground 2013 Crime Fest Last Laugh Award shortlist for The Cold Cold Ground 2013 Ned Kelly Award for Best Crime Novel shortlist for I Hear the Sirens in the Street 2014 Barry Award (for crime novels)for Best Mystery Novel (Paperback Original) for I Hear the Sirens in the Street 2014 Grand Prix de Littérature Policière shortlist for I Hear the Sirens in the Street 2014 Theakston Old Peculier Crime Novel of the Year Award shortlist for I Hear the Sirens in the Street 2014 Ned Kelly Award for Best Fiction for In the Morning I'll Be Gone 2015 Audie Award For Best Thriller shortlist for In the Morning I'll Be Gone 2015 Prix SNCF Du Polar shortlist for The Cold Cold Ground 2015 Ned Kelly Award shortlist for Gun Street Girl 2015 Boston Globe Best Book of 2015 for Gun Street Girl 2015 Irish Times Best Crime Novel of 2015 for Gun Street Girl 2016 Edgar Award (Best Paperback Original) shortlist for Gun Street Girl 2016 Anthony Award (Best Paperback Original) shortlist for Gun Street Girl 2016 Audie Award for Best Mystery shortlist for Gun Street Girl 2016 Boston Globe Best Book of 2016 for Rain Dogs 2016 Irish Times Best Crime Novel of 2016 for Rain Dogs 2016 Theakston Old Peculier Crime Novel of the Year Award shortlist for Rain Dogs 2016 Ned Kelly Award shortlist for Rain Dogs 2016 CWA Ian Fleming Steel Dagger shortlist for Rain Dogs 2017 Edgar Award (Best Paperback Original) for Rain Dogs 2017 Barry Award for Rain Dogs 2017 Anthony Award (Best Paperback Original) for Rain Dogs 2017 Ned Kelly Award for Police at the Station and They Don't Look Friendly 2017 CWA Ian Fleming Steel Dagger Award shortlist for Police at the Station and They Don't Look Friendly 2017 Boston Globe Best Book of 2017 for Police at the Station and They Don't Look Friendly 2018 International Thriller Writers Awards (Best Paperback Original Novel) shortlist for Police at the Station and They Don't Look Friendly 2019 Time magazine Books of the Year for The Chain 2020 Theakston's Old Peculier Crime Novel of the Year Award 2020 winner for The Chain. 2020 Ian Fleming Steel Dagger Award longlist for The Chain; CWA Body in the Library longlist for The Chain 2020 International Thriller Writers Award for Best Hardcover Novel, The Chain. 2020 Ned Kelly Award for Best International Crime Fiction for The Chain. 2020 Macavity Awards for Best Mystery Novel by Mystery Readers International for The Chain. 2020 Barry Award (for crime novels) for Best Mystery Novel winner for The Chain. 2022 In The Morning I'll Be Gone winner of the Prix Polar Pourpres for Best Mystery Novel 2022 Best Thrillers of 2022 for The Island. New York Times 2023 Best Thrillers of 2023 for The Detective Up Late. Washington Post 2024 Barry Award (for crime novels) nominee for Best Mystery Novel for The Detective Up Late
Sources: en.wikipedia.org
== Chemistry of experiment == In 1957 Miller published research describing the chemical processes occurring inside his experiment. Hydrogen cyanide (HCN) and aldehydes (e.g., formaldehyde) were demonstrated to form as intermediates early on in the experiment due to the electric discharge. This agrees with current understanding of atmospheric chemistry, as HCN can generally be produced from reactive radical species in the atmosphere that arise when CH4 and nitrogen break apart under ultraviolet (UV) light. Similarly, aldehydes can be generated in the atmosphere from radicals resulting from CH4 and H2O decomposition and other intermediates like methanol. Several energy sources in planetary atmospheres can induce these dissociation reactions and subsequent hydrogen cyanide or aldehyde formation, including lightning, ultraviolet light, and galactic cosmic rays. For example, here is a set photochemical reactions of species in the Miller–Urey atmosphere that can result in formaldehyde:
== Alternative medicine == Triiodothyronine has been used to treat Wilson's syndrome, an alternative medical diagnosis not recognized as a medical condition by mainstream medicine. This diagnosis involves various non-specific symptoms that are attributed to the thyroid, despite normal thyroid function tests. The American Thyroid Association has raised concern that the prescribed treatment with triiodothyronine is potentially harmful.
Broad proteomic and transcriptomic profiling has led to innumerable advances in the biomedical space, but the characterization of RNA and protein expression is limited in its ability to inform on the functional characteristics of proteins. Given that transcript and protein expression information leave gaps in knowledge surrounding the effects of post-translational modifications and protein-protein interactions on enzyme activity, and that enzyme activity varies across cell types, disease states, and physiological conditions, specialized tools are required to profile enzyme activity across contexts. Additionally, many identified enzymes have not been sufficiently characterized to yield actionable mechanisms on which to base functional assays. Without a basis for a functional biochemical readout, chemical tools are required to detect drug-protein interactions.
These include hypothetical machines that manipulate individual atoms and machines with organism-like self-replicating abilities, mobility, ability to consume food, and so forth. These are quite different from devices that merely (as defined above) "guide chemical reactions by positioning reactive molecules with atomic precision". Because synthetic molecular assemblers have never been constructed and because of the confusion regarding the meaning of the term, there has been much controversy as to whether "molecular assemblers" are possible or simply science fiction. Confusion and controversy also stem from their classification as nanotechnology, which is an active area of laboratory research which has already been applied to the production of real products; however, there had been, until recently, no research efforts into the actual construction of "molecular assemblers". Nonetheless, a 2013 paper by David Leigh's group, published in the journal Science, details a new method of synthesizing a peptide in a sequence-specific manner by using an artificial molecular machine that is guided by a molecular strand. This functions in the same way as a ribosome building proteins by assembling amino acids according to a messenger RNA blueprint. The structure of the machine is based on a rotaxane, which is a molecular ring sliding along a molecular axle. The ring carries a thiolate group, which removes amino acids in sequence from the axle, transferring them to a peptide assembly site.
The same month, she collaborated with Trainline and attended King's Cross Station to promote their "Slaystation" service, a pop-up experience where commuters were able to get their hair and make-up done. In July 2025, Collins appeared in an online advertisement campaign for Sky Mobile, for which she fronted a satire video apologising about accidentally "oversharing" details about her wedding, before revealing she was "not sorry" and subsequently endorsed them for allowing users of the network to share their mobile data. As part of the partnership, Collins said "Oversharing is caring huns, don't stress about it – I've overshared all my life and I love it. Now with Sky Mobile, we can share even more – by gifting data so that those you love can keep the group chats going strong!" In October 2025, Collins starred in an advertisement for the gambling company Paddy Power alongside Danny Dyer and Coleen Rooney, in which Collins makes her way through a casino calling after Dyer, referencing her famous meme exclaiming "I'm claustrophobic Danny" before telling Rooney to "have a day off hun". In November 2025, Collins collaborated with the online retail service AliExpress as part of their "See the Signs 11.11" campaign, which saw her attend a pop-up event in Soho where she partook in a live stream and assisted with the promotion of their products, as well as selecting a random winner to receive a giant Labubu. In February 2026, Collins collaborated with the proprietary software company Canva.
Sources: en.wikipedia.org
Reversed-phase high-performance liquid chromatography is the standard method, with detection in the ultraviolet range. Peak area percentage yields a purity figure for the main component. Mass spectrometry is normally run alongside to confirm molecular identity.
Dry lyophilised powder is generally kept at minus twenty degrees Celsius, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they encourage aggregation and moisture uptake. Solutions are less stable than the solid form and degrade faster at room temperature.
A certificate documents what the supplier measured, not what an independent party confirmed. Methods, instruments and acceptance criteria can differ between suppliers. Third-party testing is the usual way to resolve discrepancies.
It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.